Maryland company would get big boost from FDA’s Narcan decision

Gaithersburg, Maryland-based biotech Emergent BioSolutions stands to gain from a Food and Drug Administration decision to make opioid overdose drug Narcan available without a prescription. It makes the nasal spray version of the opioid-overdose antidote naloxone. An FDA advisory panel this week recommended over-the-counter availability of Narcan. While the FDA is not required to follow any recommendations from advisory panels, it usually does.